Answers are grounded in this paper and cite their sources.
Artificial intelligence (AI) is rapidly reshaping health systems worldwide, offering unprecedented opportunities but also introducing new risks. Effective governance is therefore essential to ensure that AI in health is safe, trustworthy, and aligned with public interest. This article examines emerging global t`rends in AI governance in health across a diverse set of countries. Three major trends are shaping the global governance landscape. First, national health data resources are increasingly treated as strategic assets, reflecting a shift toward digital sovereignty. Countries are investing in nationally governed health data infrastructures to enable AI development while safeguarding national interests. Second, regulators are coordinating between general AI laws and health‐specific regulations, adopting different governance approaches based on the countries' situations. Third, regulatory systems are transitioning from static, pre‐market gatekeeping to lifecycle‐based oversight. Countries such as the United States, the United Kingdom, Canada, Singapore, and China are pioneering mechanisms to manage adaptive AI systems. Beyond these, emerging themes—including regulatory sandboxes, evolving definitions of AI safety, and the prioritization of equity and digital inclusion—are reshaping national strategies. The analysis highlights the need for interoperable standards, robust data governance, and capacity‐building for regulators and health institutions.
No takes yet. Share an insight, caveat, or question.
Leal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: